Cancer Rehabilitation

Clinical Practice (assessment, diagnosis, treatment, knowledge translation/EBP, implementation science, program development)

Quality Improvement and Implementation Science

Special Symposium

(595758) SPECIAL SYMPOSIUM: Cancer Rehabilitation Guideline Development Update

Presenter(s)

• 

  Alix Sleight, PhD, OTD, MPH, OTR/L

  Cancer Prevention Fellow
  National Cancer Institute
  Bethesda, Maryland
• 

  Nicole Stout, PT, DPT, CLT-LANA, FAPTA

  Consultant
  3eServicesLLC
  Sarasota, West Virginia
• 

  Catherine Alfano, PhD

  Vice President, Survivorship
  American Cancer Society
  Washington, District of Columbia
• 

  Aneesha Virani, PhD, CCC-SLP

  Clinical Coordinator of Rehabilitation Services
  Northside Hospital
  Smyrna, Georgia

Non-presenting author(s)

• 

  Mackenzi Pergolotti, PhD OTR/L

  Director of Research
  ReVital Cancer Rehabilitation, Select Medical
  Fort Collins, Colorado
• 

  Timothy Marshall, PhD, MS, ACSM/ACS-CET

  Assistant Professor
  Kean University
  Union, New Jersey

Non-presenting Author(s)

• 

  Kathleen Lyons, ScD, OTR/L

  Scientist
  Dartmouth-Hitchcock Medical Center
  Newbury, New Hampshire

The Cancer Rehabilitation networking group of ACRM will present the results of a systematic review of the literature, a synthesis of evidence for a care delivery model, and scoping review of cancer rehabilitation guidelines. The information provided from these three projects will coalesce to inform the development of a Cancer Rehabilitation Guideline.

Learning Objectives:

• Identify the highest levels of evidence for rehabilitation interventions that address the most common cancer treatment-related impairments.
• Develop an understanding of a risk stratification model that can inform proactive screening and assessment for functional decline in individuals undergoing cancer treatment.
• Recognize the triage process for cancer rehabilitation care and the interdisciplinary nature of the referrals for intervention.
• Identify optimal functional screening, assessment, and patient reported outcomes measures for use along the cancer care continuum.